No in vitro activity of cefiderocol against OXA-427-producing Enterobacterales

J Antimicrob Chemother. 2021 Nov 12;76(12):3317-3318. doi: 10.1093/jac/dkab304.

Authors

Ann-Sophie Jacob¹, Ga-Lai Chong^{1

2}, Katrien Lagrou^{1

3}, Melissa Depypere^{1

3}, Stefanie Desmet^{1

3}

Affiliations

¹ Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
² Erasmus University Medical Center, Department of Medical Microbiology and Infectious Diseases, Rotterdam, The Netherlands.
³ Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Bacteriology and Mycology, KU Leuven, Leuven, Belgium.

PMID: 34427311
DOI: 10.1093/jac/dkab304

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Cefiderocol
Cephalosporins*
Microbial Sensitivity Tests
beta-Lactamases / genetics

Substances

Anti-Bacterial Agents
Cephalosporins
beta-Lactamases